AnalystsRudy LiRudy Li's Stock Forecasts
AnalystsRudy Li
Sectors:
Industries:
Analyst Ranking
Top 18%
#875 out of 5017 analysts
Average Return
+26.97%
Win Rate
70%16 out of 23
Risk vs Reward
Poor
Good
Rudy Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +183.29% | $8.26 | $23.40 | 2025-03-18 - 2025-09-15 | Strong Buy |
Stoke Therapeutics IncSTOK | +151.61% | $9.30 | $23.40 | 2025-02-18 - 2025-09-15 | Strong Buy |
Stoke Therapeutics IncSTOK | +100.34% | $11.68 | $23.40 | 2024-12-19 - 2025-09-15 | Strong Buy |
Prothena Corp Public Ltd CoPRTA | +78.17% | $4.58 | $8.16 | 2025-05-26 - 2025-09-15 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +77.72% | $12.39 | $22.02 | 2025-05-07 - 2025-09-15 | Strong Buy |
Rudy Li Analyst Color
Get additional color on Rudy Li's coverage of popular stocks
Rudy Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | 7 | Strong Buy | $18.00 | +120.59% | Maintains | 19 days ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $24.00 | +2.56% | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $55.00 | +52.82% | Maintains | a month ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $30.00 | +36.24% | Maintains | a month ago |
Mind Medicine IncMNMD | 4 | Strong Buy | $20.00 | +109.42% | Maintains | a month ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $80.00 | +97.78% | Maintains | 2 months ago |
Bright Minds Biosciences IncDRUG | 2 | Strong Buy | $80.00 | N/A | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.